NHI Announces Third Quarter 2021 Results
National Health Investors (NHI) reported a 29.5% decrease in net income per diluted share for Q3 2021, totaling $0.67, and a 30.2% decrease for the first nine months, at $2.31. The declines stemmed from $22.5 million in impairment charges and $4.8 million in unpaid rent from Holiday Retirement. Normalized FAD and FFO also saw declines of 15.1% and 19.0% respectively for Q3. However, NHI completed property sales totaling $216 million and expects continued asset dispositions to reach the upper end of a $250-$400 million target.
- Completed disposals of 19 properties for approximately $216 million, aiding liquidity
- Expect asset dispositions to reach upper target of $250-$400 million
- Balance sheet remains strong with no outstanding debt on revolver and significant cash reserves
- 29.5% decrease in net income per diluted share for Q3 2021
- 30.2% decrease in net income per diluted share for the first nine months
- Impairment charges of $22.5 million on five properties
- Holiday Retirement's nonpayment of $4.8 million in contractual rent
- 15.1% decrease in normalized FAD for Q3
MURFREESBORO, TN / ACCESSWIRE / November 8, 2021 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2021.
Financial Results
- Net income attributable to common stockholders per diluted common share for the three months ended September 30, 2021 was
$0.67 , a decrease of29.5% from the same period in the prior year. Net income attributable to common stockholders per diluted common share for the nine months ended September 30, 2021 was$2.31 , a decrease of30.2% from the same period in the prior year. The nine month decline is attributable to impairment charges recorded on five real estate properties totaling$22.5 million ,$17.2 million additional rent deferrals incurred during the nine months ended September 30, 2021, Holiday Retirement's ("Holiday") nonpayment of contractual rent of$4.8 million and a$4.7 million year-over-year increase in non-cash stock-based compensation. These declines were offset by increases of approximately$5.4 million in gains from the sales of real estate assets as compared to the same period in the prior year and new investments funded since September 2020. - Normalized FAD for the three months ended September 30, 2021 was
$51.2 million , a decrease of15.1% from the same period in the prior year. Normalized FAD for the nine months ended September 30, 2021 was$163.6 million , a decrease of9.5% from the same period in the prior year. - Normalized FFO per diluted common share for the three months ended September 30, 2021 was
$1.15 , a decrease of19.0% from the same period in the prior year. Normalized FFO per diluted common share for the nine months ended September 30, 2021 was$3.55 , a decrease of16.1% from the same period in the prior year. - National Association of Real Estate Investment Trusts ("NAREIT") FFO per diluted common share for the three months ended September 30, 2021 was
$1.16 , a decrease of18.3% from the same period in the prior year. NAREIT FFO per diluted common share for the nine months ended September 30, 2021 was$3.55 , a decrease of15.9% from the same period in the prior year. - Net income, Normalized FFO and NAREIT FFO per common share for the three and nine months ended September 30, 2021 include the dilutive impact of 1,121,442 common shares issued since September 30, 2020.
Eric Mendelsohn, NHI President and CEO, stated, "We have made tremendous progress on optimizing our portfolio this year. We have completed dispositions of 19 properties for approximately
Mr. Mendelsohn continued, "We have reduced our tenant concentrations with both Bickford and Holiday and have established frameworks that we believe greatly improve the coverage and growth profiles of NHI. Our balance sheet is in great shape as we have reduced leverage despite our tenant deferrals and Holiday's non-payment of rent. We have full capacity on our revolver and little need to issue new equity as we pivot towards growth."
Mr. Mendelsohn concluded, "This year has been as challenging as we anticipated, and our operators continue to struggle particularly with labor. Fortunately, NHI is in a good position to assist our partners through these near-term issues, and we remain resolute in our favorable outlook on the long-term growth prospects of the senior housing industry."
Asset Dispositions
Senior Living Management: On September 30 2021, NHI sold a senior living community located in Florida for cash consideration of
Quorum Health: In September 2021, NHI sold an acute care hospital located in Kentucky for cash consideration of
In September 2021, NHI sold a property that was leased to Holiday located in Indiana with a net book value of
Holiday: In August 2021, NHI sold a portfolio of eight properties that was leased to Holiday with an aggregate net book value of
TrustPoint Hospital: In July 2021, NHI sold a behavioral hospital located in Tennessee for cash consideration of
Assets Held for Sale & Impairment of Real Estate
During the third quarter of 2021, the Company reclassified three transition properties to assets held for sale on the Condensed Consolidated Balance Sheet at September 30, 2021 and recorded impairment charges of approximately
As discussed above, NHI recognized real estate impairment charges of approximately
Collections and Deferrals
During the third quarter of 2021, NHI granted rent concessions in the form of rent deferrals totaling approximately
For the nine months ended September 30, 2021, NHI granted rent concessions in the form of rent deferrals totaling approximately
NHI has agreed with Bickford to defer
Occupancy
The following table summarizes the average portfolio occupancy for Senior Living Communities ("SLC"), Bickford and Holiday for the periods indicated, excluding development properties in operation less than 24 months, notes receivable, and properties transitioned to new operators or disposed.
Properties | 3Q20 | 4Q20 | 1Q21 | 2Q21 | 3Q21 | Sep-21 | |||||||
SLC | 9 | 79.0 | % | 77.3 | % | 77.7 | % | 78.5 | % | 80.4 | % | 80.9 | % |
Bickford1 | 42 | 81.2 | % | 79.1 | % | 75.0 | % | 77.4 | % | 80.2 | % | 80.7 | % |
Holiday2 | 17 | 81.7 | % | 78.8 | % | 75.6 | % | 75.8 | % | 77.8 | % | 78.9 | % |
1Prior period occupancies have been restated to include an additional building, in operation for at least 24-months, and the sale of six properties in the second quarter of 2021.
2Holiday occupancy for 17 properties is restated retroactively to reflect the sale of the Fort Wayne, IN property and the sale of eight properties in the third quarter of 2021.
Balance Sheet and Liquidity
At October 31, 2021, NHI had no amount outstanding under a
Investor Conference Call and Webcast
NHI will host a conference call on Monday, November 8, 2021, at 5:00 p.m. ET, to discuss third quarter results. The number to call for this interactive teleconference is (877) 412-4946, with the confirmation number 21998400. The live broadcast of NHI's third quarter conference call will be available online at www.nhireit.com. The online replay will follow shortly after the call and remain available for one year.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. Visit www.nhireit.com for more information.
Reconciliation of FFO, Normalized FFO and Normalized FAD
($ in thousands, except share and per share amounts)
| Three Months Ended | Six Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
Net income attributable to common stockholders | $ | 30,814 | $ | 42,595 | $ | 105,327 | $ | 147,986 | ||||||||
Elimination of certain non-cash items in net income: | ||||||||||||||||
Depreciation | 20,035 | 20,836 | 61,499 | 62,126 | ||||||||||||
Depreciation related to noncontrolling interests | (210 | ) | (210 | ) | (629 | ) | (567 | ) | ||||||||
Gains on sales of real estate, net | (19,941 | ) | - | (26,426 | ) | (21,007 | ) | |||||||||
Impairment of real estate | 22,462 | - | 22,462 | - | ||||||||||||
NAREIT FFO attributable to common stockholders | 53,160 | 63,221 | 162,233 | 188,538 | ||||||||||||
Loss on early retirement of debt | - | - | 451 | - | ||||||||||||
Non-cash write-off of straight-line rent receivable | - | - | - | 380 | ||||||||||||
Recognition of unamortized note receivable commitment fees | (375 | ) | - | (375 | ) | - | ||||||||||
Litigation settlement | (266 | ) | - | (266 | ) | - | ||||||||||
Normalized FFO attributable to common stockholders | 52,519 | 63,221 | 162,043 | 188,918 | ||||||||||||
Straight-line lease revenue, net | (3,798 | ) | (5,086 | ) | (12,189 | ) | (15,861 | ) | ||||||||
Straight-line lease revenue, net, related to noncontrolling interests | 20 | 29 | 65 | 81 | ||||||||||||
Straight-line lease expense related to equity method investment | 11 | 31 | 56 | 82 | ||||||||||||
Amortization of lease incentives | 252 | 250 | 774 | 735 | ||||||||||||
Amortization of original issue discount | 80 | 102 | 214 | 303 | ||||||||||||
Amortization of debt issuance costs | 556 | 871 | 1,849 | 2,156 | ||||||||||||
Amortization related to equity method investment | 268 | 537 | 1,324 | 535 | ||||||||||||
Note receivable credit loss expense | (37 | ) | (193 | ) | 1,134 | 1,002 | ||||||||||
Non-cash stock-based compensation | 989 | 457 | 7,427 | 2,772 | ||||||||||||
Equity method investment capital expenditures | (105 | ) | (105 | ) | (315 | ) | (315 | ) | ||||||||
Equity method investment non-refundable fees received | 418 | 156 | 1,179 | 330 | ||||||||||||
Normalized FAD attributable to common stockholders | $ | 51,173 | $ | 60,270 | $ | 163,561 | $ | 180,738 | ||||||||
BASIC | ||||||||||||||||
Weighted average common shares outstanding | 45,850,599 | 44,661,650 | 45,668,762 | 44,641,748 | ||||||||||||
NAREIT FFO attributable to common stockholders per share | $ | 1.16 | $ | 1.42 | $ | 3.55 | $ | 4.22 | ||||||||
Normalized FFO attributable to common stockholders per share | $ | 1.15 | $ | 1.42 | $ | 3.55 | $ | 4.23 | ||||||||
DILUTED | ||||||||||||||||
Weighted average common shares outstanding | 45,851,424 | 44,662,403 | 45,689,091 | 44,643,514 | ||||||||||||
NAREIT FFO attributable to common stockholders per share | $ | 1.16 | $ | 1.42 | $ | 3.55 | $ | 4.22 | ||||||||
Normalized FFO attributable to common stockholders per share | $ | 1.15 | $ | 1.42 | $ | 3.55 | $ | 4.23 | ||||||||
See Notes to Reconciliation of FFO, Normalized FFO and Normalized FAD.
Notes to Reconciliation of FFO, Normalized FFO and Normalized FAD
These supplemental performance measures may not be comparable to similarly titled measures used by other REITs. Consequently, our Funds From Operations ("FFO"), Normalized FFO and Normalized Funds Available for Distribution ("FAD") may not provide a meaningful measure of our performance as compared to that of other REITs. Since other REITs may not use our definition of these performance measures, caution should be exercised when comparing our FFO, Normalized FFO and Normalized FAD to that of other REITs. These financial performance measures do not represent cash generated from operating activities in accordance with generally accepted accounting principles ("GAAP") (these measures do not include changes in operating assets and liabilities) and therefore should not be considered an alternative to net earnings as an indication of performance, or to net cash flow from operating activities as determined by GAAP as a measure of liquidity, and are not necessarily indicative of cash available to fund cash needs. Beginning in the first quarter of 2021, the Company is no longer presenting Adjusted Funds from Operations as a supplemental measure of operating performance.
Funds From Operations - FFO
FFO, as defined by NAREIT and applied by us, is net income (computed in accordance with GAAP), excluding gains (or losses) from sales of real estate property, plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures, if any. The Company's computation of FFO may not be comparable to FFO reported by other REITs that do not define the term in accordance with the current NAREIT definition or have a different interpretation of the current NAREIT definition from that of the Company; therefore, caution should be exercised when comparing our Company's FFO to that of other REITs. Diluted FFO assumes the exercise of stock options and other potentially dilutive securities. Normalized FFO excludes from FFO certain items which, due to their infrequent or unpredictable nature, may create some difficulty in comparing FFO for the current period to similar prior periods, and may include, but are not limited to, impairment of non-real estate assets, gains and losses attributable to the acquisition and disposition of assets and liabilities, and recoveries of previous write-downs.
FFO and Normalized FFO are important supplemental measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that uses historical cost accounting for depreciation could be less informative, and should be supplemented with a measure such as FFO. The term FFO was designed by the REIT industry to address this issue.
Funds Available for Distribution - FAD
In addition to the adjustments included in the calculation of Normalized FFO, Normalized FAD excludes the impact of any straight-line rent revenue, amortization of the original issue discount on our senior unsecured notes, amortization of debt issuance costs, non-cash stock based compensation, as well as certain non-cash items related to our equity method investment.
Normalized FAD is an important supplemental performance measure for a REIT. GAAP requires a lessor to recognize contractual lease payments into income on a straight-line basis over the expected term of the lease. This straight-line adjustment has the effect of reporting lease income that is significantly more or less than the contractual cash flows received pursuant to the terms of the lease agreement. GAAP also requires any discount or premium related to indebtedness and debt issuance costs to be amortized as non-cash adjustments to earnings. The Company also adjusts Normalized FAD for the net change in the allowance for expected credit losses, non-cash stock based compensation as well as certain non-cash items related to equity method investments such as straight-line lease expense and amortization of purchase accounting adjustments. Normalized FAD is an important supplemental measure of liquidity for a REIT as a useful indicator of the ability to distribute dividends to stockholders.
Condensed Consolidated Statements of Income
(in thousands, except share and per share amounts)
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| (unaudited) | (unaudited) | |||||||||||||||
Revenues: | ||||||||||||||||
Rental income | $ | 67,043 | $ | 77,821 | $ | 210,143 | $ | 232,266 | ||||||||
Interest income and other | 6,790 | 6,480 | 18,905 | 19,306 | ||||||||||||
| 73,833 | 84,301 | 229,048 | 251,572 | |||||||||||||
Expenses: | ||||||||||||||||
Depreciation | 20,035 | 20,836 | 61,499 | 62,126 | ||||||||||||
Interest | 12,715 | 12,892 | 38,528 | 40,589 | ||||||||||||
Legal | 117 | 241 | 207 | 826 | ||||||||||||
Franchise, excise and other taxes | 244 | 164 | 709 | 553 | ||||||||||||
General and administrative | 3,650 | 2,785 | 15,229 | 10,127 | ||||||||||||
Taxes and insurance on leased properties | 3,182 | 4,187 | 7,519 | 7,190 | ||||||||||||
Loan and realty losses (gains) | 22,425 | (193 | ) | 23,596 | 1,002 | |||||||||||
| 62,368 | 40,912 | 147,287 | 122,413 | |||||||||||||
Loss from equity method investment | (557 | ) | (728 | ) | (2,274 | ) | (2,018 | ) | ||||||||
Loss on early retirement of debt | - | - | (451 | ) | - | |||||||||||
Gains on sales of real estate, net | 19,941 | - | 26,426 | 21,007 | ||||||||||||
Net income | 30,849 | 42,661 | 105,462 | 148,148 | ||||||||||||
Less: net income attributable to noncontrolling interests | (35 | ) | (66 | ) | (135 | ) | (162 | ) | ||||||||
Net income attributable to common stockholders | $ | 30,814 | $ | 42,595 | $ | 105,327 | $ | 147,986 | ||||||||
Weighted average common shares outstanding: | ||||||||||||||||
Basic | 45,850,599 | 44,661,650 | 45,668,762 | 44,641,748 | ||||||||||||
Diluted | 45,851,424 | 44,662,403 | 45,689,091 | 44,643,514 | ||||||||||||
Earnings per common share: | ||||||||||||||||
Net income attributable to common stockholders - basic | $ | 0.67 | $ | 0.95 | $ | 2.31 | $ | 3.31 | ||||||||
Net income attributable to common stockholders - diluted | $ | 0.67 | $ | 0.95 | $ | 2.31 | $ | 3.31 | ||||||||
Selected Balance Sheet Data
($ in thousands)
| September 30, 2021 | December 31, 2020 | |||||||
Real estate properties, net | $ | 2,428,449 | $ | 2,667,432 | ||||
Mortgage and other notes receivable, net | $ | 284,608 | $ | 292,427 | ||||
Cash and cash equivalents | $ | 48,393 | $ | 43,344 | ||||
Straight-line rent receivable | $ | 99,895 | $ | 95,703 | ||||
Assets held for sale, net | $ | 17,443 | $ | - | ||||
Other assets | $ | 33,389 | $ | 21,583 | ||||
Debt | $ | 1,285,287 | $ | 1,499,285 | ||||
National Health Investors Stockholders' Equity | $ | 1,539,057 | $ | 1,512,234 | ||||
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company's, tenants', operators', borrowers' or managers' expected future financial position, results of operations, cash flows, funds from operations, dividend and dividend plans, financing opportunities and plans, capital market transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, acquisition integration, growth opportunities, expected lease income, continued qualification as a real estate investment trust ("REIT"), plans and objectives of management for future operations, continued performance improvements, ability to service and refinance our debt obligations, ability to finance growth opportunities, and similar statements including, without limitation, those containing words such as "may", "will", "believes", "anticipates", "expects", "intends", "estimates", "plans", and other similar expressions are forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Such risks and uncertainties include, among other things; the impact of COVID-19 on our tenants, borrowers, economy and the Company; the operating success of our tenants and borrowers for collection of our lease and interest income; the success of property development and construction activities, which may fail to achieve the operating results we expect; the risk that our tenants and borrowers may become subject to bankruptcy or insolvency proceedings; risks related to governmental regulations and payors, principally Medicare and Medicaid, and the effect that lower reimbursement rates would have on our tenants' and borrowers' business; the risk that the cash flows of our tenants and borrowers would be adversely affected by increased liability claims and liability insurance costs; risks related to environmental laws and the costs associated with liabilities related to hazardous substances; the risk that we may not be fully indemnified by our lessees and borrowers against future litigation; the success of our future acquisitions and investments; our ability to reinvest cash in real estate investments in a timely manner and on acceptable terms; the potential need to incur more debt in the future, which may not be available on terms acceptable to us; our ability to meet covenants related to our indebtedness which impose certain operational limitations and a breach of those covenants could materially adversely affect our financial condition and results of operations; the risk that the illiquidity of real estate investments could impede our ability to respond to adverse changes in the performance of our properties; risks associated with our investments in unconsolidated entities, including our lack of sole decision-making authority and our reliance on the financial condition of other interests; our dependence on revenues derived mainly from fixed rate investments in real estate assets, while a portion of our debt bears interest at variable rates; the risk that our assets may be subject to impairment charges; and our dependence on the ability to continue to qualify for taxation as a real estate investment trust. Many of these factors are beyond the control of the Company and its management. The Company assumes no obligation to update any of the foregoing or any other forward looking statements, except as required by law, and these statements speak only as of the date on which they are made. Investors are urged to carefully review and consider the various disclosures made by NHI in its periodic reports filed with the Securities and Exchange Commission, including the risk factors and other information disclosed in NHI's Annual Report on Form 10-K for the most recently ended fiscal year. Copies of these filings are available at no cost on the SEC's web site at https://www.sec.gov or on NHI's web site at https://www.nhireit.com.
SOURCE: National Health Investors
View source version on accesswire.com:
https://www.accesswire.com/671681/NHI-Announces-Third-Quarter-2021-Results
FAQ
What is National Health Investors' (NHI) net income for Q3 2021?
What were the primary reasons for NHI's income decline in nine months ended September 30, 2021?
How much did NHI earn from property sales in 2021?
What are the expectations for NHI's asset dispositions going forward?
What is the status of NHI's balance sheet?
